Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Tan

Showing results (1061-1070 of 1,101) with videos related to

Pageof 111
Sort By:
Nature Aging|April 28, 2023
Detecting visually significant cataract using retinal photograph-based deep learningYih-Chung Tham, Jocelyn Hui Lin Goh, Ayesha Anees, et al.
Physical Review Letters|February 23, 2024
Measurement of the ^{13}C(α, n_{0})^{16}O Differential Cross Section from 0.8 to 6.5 MeVR J deBoer, M Febbraro, D W Bardayan, et al.
Physical Review Letters|November 10, 2015
Mass Measurement of 56Sc Reveals a Small A = 56 Odd-Even Mass Staggering, Implying a Cooler Accreted Neutron Star CrustZ Meisel, S George, S Ahn, et al.
Journal for Immunotherapy of Cancer|February 26, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignanciesPatrick Schöffski, Daniel S W Tan, Miguel Martín, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Clinical Cardiology|November 14, 2018
Platelet inhibition to target reperfusion injury trial: Rationale and study designHeerajnarain Bulluck, Mervyn H H Chan, Jennifer A Bryant, et al.
Oncogene|November 8, 2016
TET2 binds the androgen receptor and loss is associated with prostate cancerM L Nickerson, S Das, K M Im, et al.
Oral Oncology|October 22, 2020
Pairing a prognostic target with potential therapeutic strategy for head and neck cancerSze Min Lek, Ke Li, Qiu Xuan Tan, et al.
The British Journal of Dermatology|September 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial)T H Sach, K S Thomas, J M Batchelor, et al.
Pageof 111

Showing results (1061-1070 of 1,101) with videos related to

Sort By:
Pageof 111
Nature Aging|April 28, 2023
Detecting visually significant cataract using retinal photograph-based deep learningYih-Chung Tham, Jocelyn Hui Lin Goh, Ayesha Anees, et al.
Physical Review Letters|February 23, 2024
Measurement of the ^{13}C(α, n_{0})^{16}O Differential Cross Section from 0.8 to 6.5 MeVR J deBoer, M Febbraro, D W Bardayan, et al.
Physical Review Letters|November 10, 2015
Mass Measurement of 56Sc Reveals a Small A = 56 Odd-Even Mass Staggering, Implying a Cooler Accreted Neutron Star CrustZ Meisel, S George, S Ahn, et al.
Journal for Immunotherapy of Cancer|February 26, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignanciesPatrick Schöffski, Daniel S W Tan, Miguel Martín, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Clinical Cardiology|November 14, 2018
Platelet inhibition to target reperfusion injury trial: Rationale and study designHeerajnarain Bulluck, Mervyn H H Chan, Jennifer A Bryant, et al.
Oncogene|November 8, 2016
TET2 binds the androgen receptor and loss is associated with prostate cancerM L Nickerson, S Das, K M Im, et al.
Oral Oncology|October 22, 2020
Pairing a prognostic target with potential therapeutic strategy for head and neck cancerSze Min Lek, Ke Li, Qiu Xuan Tan, et al.
The British Journal of Dermatology|September 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial)T H Sach, K S Thomas, J M Batchelor, et al.
Pageof 111